Malignant melanoma, Colorectal carcinoma, Hematologic neoplasms, Lung cancer
Conditions
Interventions
Group 1: Intervention arm: Participants in the intervention arm receive a complex supportive care intervention in addition to usual care. The intervention includes a social prescription with individua
Sponsors
Universität Regensburg
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1) diagnosis of early-stage or advanced-stage lung cancer, colorectal cancer, hematological neoplasm or malignant melanoma 2) primary diagnosis within the past 12 months 3) expected survival of at least 18 months 4) attendance at the medical oncology units of participating hospitals 5) ECOG Performance Status 0-2 6) sufficient German language proficiency to complete questionnaires and interviews 7) ability to name an eligible SP 8) provision auf written informed cosent
Exclusion criteria
Exclusion criteria: 1) inability to provide informed consent 2) inability independently complete interviews and/or questionnaires due to impaired speech, vigilance, or comprehension.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of life at 6 months after baseline, measured using the global health score of the EORTC QLQ-F17. Quality of life will also be assessed at baseline, 4 weeks, 3 months, and 12 months for longitudinal analyses. | — |
Secondary
| Measure | Time frame |
|---|---|
| Self-efficacy, assessed using the Cancer Behavior Inventory Brief Version (CBI-B-D-12). Knowledge of health and care, measured using self-developed items. Healthcare utilization and supportive care use, measured by the number of hospital admissions, length of hospital stays, and documentation of supportive care services. | — |
Countries
Germany
Contacts
Public ContactChristine Bernardi
Universität Regensburg, Institut für Epidemiologie und Präventivmedizin, Medizinische Soziologie
Outcome results
None listed